English

SYRA HEALTH CORP.

EDGAR

SYRA Current report (8-K) · filed 2026-11-03

Annual consolidated revenue for 2025: about USD 7.226M, using the latest reported figures. The previous period, 2024, was about USD 7.982M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.56 million USD

2026 Q3 · USD

Exact inputs and evidence

Revenue: 2557295 USD Source

Operating margin

11.73%

2026 Q3 · %

Exact inputs and evidence

Operating Income: 300002 USD Source
Revenue: 2557295 USD Source

Operating cash flow

332 thousand USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 975023 USD Source
Operating Cash Flow: 643183 USD Source

Cash and cash equivalents: 2.38 million USD 2026-09-30 Source
Exact value

2383413 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

8.96 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Revenue: 7225973 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 5491944 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 2273520 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 2394423 USD · 2026-04-01 – 2026-06-30 Source
Revenue: 2557295 USD · 2026-07-01 – 2026-09-30 Source

Net income

701 thousand USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Net income: -896333 USD · 2025-01-01 – 2025-12-31 Source
Net income: -761763 USD · 2025-01-01 – 2025-09-30 Source
Net income: 240979 USD · 2026-01-01 – 2026-03-31 Source
Net income: 250242 USD · 2026-04-01 – 2026-06-30 Source
Net income: 344610 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

686 thousand USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Operating cash flow: -447746 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -158554 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 1361945 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 643183 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: 1361945 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 975023 USD · 2026-01-01 – 2026-09-30 Source
Operating cash flow: 643183 USD · 2026-01-01 – 2026-06-30 Source

Capital expenditure

11.1 thousand USD

2024-01-01 – 2024-12-31

Exact inputs and evidence

Capital expenditure: 5619 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 11111 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 5619 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 11111 USD · 2024-01-01 – 2024-09-30 Source
Capital expenditure: 11111 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 11111 USD · 2024-01-01 – 2024-12-31 Source
Capital expenditure: 11111 USD · 2024-01-01 – 2024-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-11-03.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2025-12-31
Operating income: 4 of 11 periods available· newest 2025-12-31
Net income: 4 of 11 periods available· newest 2025-12-31
Operating cash flow: 4 of 11 periods available· newest 2025-12-31
Capital expenditure: 4 of 11 periods available· newest 2025-12-31
Total assets: 4 of 11 periods available· newest 2025-12-31
Total liabilities: 4 of 11 periods available· newest 2025-12-31
Current assets: 4 of 11 periods available· newest 2025-12-31
Current liabilities: 4 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-9.5%

Prior period

USD 7.98 million

2024-01-01 – 2024-12-31
Current period

USD 7.23 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

7225973 − 7982082 = -756109 USD

7982082 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
7225973 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SYRA HEALTH CORP. · 2025-12-31 SYRA HEALTH CORP. (edgar:1922335) Year-over-year change in Revenue: -756109 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 7225973 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#829157 Filing: 000149315226009909 Input fundies:Revenue: 7982082 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#829586 Filing: 000149315226009909
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 2.86 million

Prior period

−USD 3.76 million

2024-01-01 – 2024-12-31
Current period

−USD 896,333

2025-01-01 – 2025-12-31

Exact inputs and evidence

-896333 − -3759238 = 2862905 USD

-3759238 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-896333 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SYRA HEALTH CORP. · 2025-12-31 SYRA HEALTH CORP. (edgar:1922335) Year-over-year change in Net income: 2862905 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -896333 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#748051 Filing: 000149315226009909 Input fundies:NetIncome: -3759238 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#748417 Filing: 000149315226009909
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.48 million

Prior period

−USD 2.93 million

2024-01-01 – 2024-12-31
Current period

−USD 447,746

2025-01-01 – 2025-12-31

Exact inputs and evidence

-447746 − -2932033 = 2484287 USD

-2932033 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-447746 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SYRA HEALTH CORP. · 2025-12-31 SYRA HEALTH CORP. (edgar:1922335) Year-over-year change in Operating cash flow: 2484287 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -447746 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#761598 Filing: 000149315226009909 Input fundies:OperatingCashFlow: -2932033 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#762059 Filing: 000149315226009909
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-99%

Prior period

USD 11,111

2024-01-01 – 2024-12-31
Current period

USD 107

2025-01-01 – 2025-12-31

Exact inputs and evidence

107 − 11111 = -11004 USD

11111 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
107 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SYRA HEALTH CORP. · 2025-12-31 SYRA HEALTH CORP. (edgar:1922335) Year-over-year change in Capital expenditure: -11004 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 107 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#763704 Filing: 000149315226009909 Input fundies:CapitalExpenditure: 11111 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#764152 Filing: 000149315226009909
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 7.23 million 100% of revenue
Cost of revenue USD 4.74 million 66% of revenue
Operating expenses USD 3.39 million 47% of revenue
Operating income −USD 904,324 −13% of revenue
Tax, interest and other Derived −USD 7,991 −0.1% of revenue
Net income −USD 896,333 −12% of revenue

Cash

Operating cash flow −USD 447,746 −6.2% of revenue
Capital expenditure USD 107 0% of revenue
Free cash flow Derived −USD 447,853 −6.2% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2022 Operating loss: operating costs were 137% of revenue.
2023 Operating loss: operating costs were 152% of revenue.
2024 Operating loss: operating costs were 147% of revenue.
2025 Operating loss: operating costs were 113% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2022 2022-01-01 – 2022-12-31	5617706	7707401 Derived	-2089695	28470 Derived	-2118165	-2365325 Derived	Source 2022-01-01 – 2022-12-31: 5617706 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -2089695 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -2118165 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -2244065 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 121260 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	5515144	8402743 Derived	-2887599	50744 Derived	-2938343	-2774319 Derived	Source 2023-01-01 – 2023-12-31: 5515144 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -2887599 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -2938343 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -2759068 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 15251 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	7982082	11746967 Derived	-3764885	-5647 Derived	-3759238	-2943144 Derived	Source 2024-01-01 – 2024-12-31: 7982082 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -3764885 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -3759238 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -2932033 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 11111 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	7225973	8130297 Derived	-904324	-7991 Derived	-896333	-447853 Derived	Source 2025-01-01 – 2025-12-31: 7225973 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -904324 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -896333 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -447746 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 107 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 7.2M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20222022-12-31	Revenue	5617706	Revenue: 5617706 Open source
20232023-12-31	Revenue	5515144	Revenue: 5515144 Open source
20242024-12-31	Revenue	7982082	Revenue: 7982082 Open source
20252025-12-31	Revenue	7225973	Revenue: 7225973 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-9.5% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20222022-12-31	Year over year	No prior comparable period	Revenue: 5617706 Open source
20232023-12-31	Year over year	-1.8%	Revenue: 5515144 Open source Revenue: 5617706 Open source
20242024-12-31	Year over year	44.7%	Revenue: 7982082 Open source Revenue: 5515144 Open source
20252025-12-31	Year over year	-9.5%	Revenue: 7225973 Open source Revenue: 7982082 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -12.5% 2025

Net margin -12.4% 2025

Free cash flow margin -6.2% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20222022-12-31	Operating margin	-37.2%	Operating Income: -2089695 Open source Revenue: 5617706 Open source
20232023-12-31	Operating margin	-52.4%	Operating Income: -2887599 Open source Revenue: 5515144 Open source
20242024-12-31	Operating margin	-47.2%	Operating Income: -3764885 Open source Revenue: 7982082 Open source
20252025-12-31	Operating margin	-12.5%	Operating Income: -904324 Open source Revenue: 7225973 Open source
20222022-12-31	Net margin	-37.7%	Net Income: -2118165 Open source Revenue: 5617706 Open source
20232023-12-31	Net margin	-53.3%	Net Income: -2938343 Open source Revenue: 5515144 Open source
20242024-12-31	Net margin	-47.1%	Net Income: -3759238 Open source Revenue: 7982082 Open source
20252025-12-31	Net margin	-12.4%	Net Income: -896333 Open source Revenue: 7225973 Open source
20222022-12-31	Free cash flow margin	-42.1%	Revenue: 5617706 Open source Operating Cash Flow: -2244065 Open source Capital Expenditure: 121260 Open source
20232023-12-31	Free cash flow margin	-50.3%	Revenue: 5515144 Open source Operating Cash Flow: -2759068 Open source Capital Expenditure: 15251 Open source
20242024-12-31	Free cash flow margin	-36.9%	Revenue: 7982082 Open source Operating Cash Flow: -2932033 Open source Capital Expenditure: 11111 Open source
20252025-12-31	Free cash flow margin	-6.2%	Revenue: 7225973 Open source Operating Cash Flow: -447746 Open source Capital Expenditure: 107 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -447.7K 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20222022-12-31	Operating cash flow	-2244065	Operating Cash Flow: -2244065 Open source
20232023-12-31	Operating cash flow	-2759068	Operating Cash Flow: -2759068 Open source
20242024-12-31	Operating cash flow	-2932033	Operating Cash Flow: -2932033 Open source
20252025-12-31	Operating cash flow	-447746	Operating Cash Flow: -447746 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -447.9K 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20222022-12-31	Free cash flow	-2365325	Operating Cash Flow: -2244065 Open source Capital Expenditure: 121260 Open source
20232023-12-31	Free cash flow	-2774319	Operating Cash Flow: -2759068 Open source Capital Expenditure: 15251 Open source
20242024-12-31	Free cash flow	-2943144	Operating Cash Flow: -2932033 Open source Capital Expenditure: 11111 Open source
20252025-12-31	Free cash flow	-447853	Operating Cash Flow: -447746 Open source Capital Expenditure: 107 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

24.3% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20222022-12-31	Liabilities / assets	69.4%	Total Liabilities: 1609544 Open source Total Assets: 2319642 Open source
20232023-12-31	Liabilities / assets	18.5%	Total Liabilities: 910072 Open source Total Assets: 4923283 Open source
20242024-12-31	Liabilities / assets	21.8%	Total Liabilities: 800761 Open source Total Assets: 3679332 Open source
20252025-12-31	Liabilities / assets	24.3%	Total Liabilities: 674739 Open source Total Assets: 2772917 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.06× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20222022-12-31	Current assets / current liabilities	0.92×	Current Assets: 1426743 Open source Current Liabilities: 1546345 Open source
20232023-12-31	Current assets / current liabilities	5.25×	Current Assets: 4781110 Open source Current Liabilities: 910072 Open source
20242024-12-31	Current assets / current liabilities	5.46×	Current Assets: 3352795 Open source Current Liabilities: 613549 Open source
20252025-12-31	Current assets / current liabilities	4.06×	Current Assets: 2738530 Open source Current Liabilities: 674739 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2022 2022-01-01 – 2022-12-31	−USD 2.12 million Exact value Exact value: -2118165 USD 2022-01-01 – 2022-12-31: -2118165 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYRA HEALTH CORP. · 2022-12-31 SYRA HEALTH CORP. (edgar:1922335) Net Income: -2118165 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2118165 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315224011121/form10-k.htm#771108 Filing: 000149315224011121 The citation records this snapshot. The page link may show a newer release later.	−USD 2.24 million Exact value Exact value: -2244065 USD 2022-01-01 – 2022-12-31: -2244065 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYRA HEALTH CORP. · 2022-12-31 SYRA HEALTH CORP. (edgar:1922335) Operating Cash Flow: -2244065 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2244065 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315224011121/form10-k.htm#785449 Filing: 000149315224011121 The citation records this snapshot. The page link may show a newer release later.	USD 121,260 Exact value Exact value: 121260 USD 2022-01-01 – 2022-12-31: 121260 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYRA HEALTH CORP. · 2022-12-31 SYRA HEALTH CORP. (edgar:1922335) Capital Expenditure: 121260 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 121260 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315224011121/form10-k.htm#787590 Filing: 000149315224011121 The citation records this snapshot. The page link may show a newer release later.	−USD 2.37 million Calculation and evidence -2244065 − 121260 USD Exact free cash flow: -2365325 USD 2022-01-01 – 2022-12-31: -2244065 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 121260 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYRA HEALTH CORP. · 2022-12-31 SYRA HEALTH CORP. (edgar:1922335) Free cash flow: -2365325 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2244065 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315224011121/form10-k.htm#785449 Filing: 000149315224011121 Input fundies:CapitalExpenditure: 121260 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315224011121/form10-k.htm#787590 Filing: 000149315224011121 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 2.94 million Exact value Exact value: -2938343 USD 2023-01-01 – 2023-12-31: -2938343 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYRA HEALTH CORP. · 2023-12-31 SYRA HEALTH CORP. (edgar:1922335) Net Income: -2938343 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2938343 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315225009873/form10-k.htm#725235 Filing: 000149315225009873 The citation records this snapshot. The page link may show a newer release later.	−USD 2.76 million Exact value Exact value: -2759068 USD 2023-01-01 – 2023-12-31: -2759068 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYRA HEALTH CORP. · 2023-12-31 SYRA HEALTH CORP. (edgar:1922335) Operating Cash Flow: -2759068 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2759068 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315225009873/form10-k.htm#738840 Filing: 000149315225009873 The citation records this snapshot. The page link may show a newer release later.	USD 15,251 Exact value Exact value: 15251 USD 2023-01-01 – 2023-12-31: 15251 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYRA HEALTH CORP. · 2023-12-31 SYRA HEALTH CORP. (edgar:1922335) Capital Expenditure: 15251 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15251 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315225009873/form10-k.htm#740936 Filing: 000149315225009873 The citation records this snapshot. The page link may show a newer release later.	−USD 2.77 million Calculation and evidence -2759068 − 15251 USD Exact free cash flow: -2774319 USD 2023-01-01 – 2023-12-31: -2759068 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 15251 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYRA HEALTH CORP. · 2023-12-31 SYRA HEALTH CORP. (edgar:1922335) Free cash flow: -2774319 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2759068 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315225009873/form10-k.htm#738840 Filing: 000149315225009873 Input fundies:CapitalExpenditure: 15251 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315225009873/form10-k.htm#740936 Filing: 000149315225009873 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 3.76 million Exact value Exact value: -3759238 USD 2024-01-01 – 2024-12-31: -3759238 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYRA HEALTH CORP. · 2024-12-31 SYRA HEALTH CORP. (edgar:1922335) Net Income: -3759238 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3759238 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#748417 Filing: 000149315226009909 The citation records this snapshot. The page link may show a newer release later.	−USD 2.93 million Exact value Exact value: -2932033 USD 2024-01-01 – 2024-12-31: -2932033 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYRA HEALTH CORP. · 2024-12-31 SYRA HEALTH CORP. (edgar:1922335) Operating Cash Flow: -2932033 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2932033 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#762059 Filing: 000149315226009909 The citation records this snapshot. The page link may show a newer release later.	USD 11,111 Exact value Exact value: 11111 USD 2024-01-01 – 2024-12-31: 11111 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYRA HEALTH CORP. · 2024-12-31 SYRA HEALTH CORP. (edgar:1922335) Capital Expenditure: 11111 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11111 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#764152 Filing: 000149315226009909 The citation records this snapshot. The page link may show a newer release later.	−USD 2.94 million Calculation and evidence -2932033 − 11111 USD Exact free cash flow: -2943144 USD 2024-01-01 – 2024-12-31: -2932033 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 11111 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYRA HEALTH CORP. · 2024-12-31 SYRA HEALTH CORP. (edgar:1922335) Free cash flow: -2943144 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2932033 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#762059 Filing: 000149315226009909 Input fundies:CapitalExpenditure: 11111 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#764152 Filing: 000149315226009909 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 896,333 Exact value Exact value: -896333 USD 2025-01-01 – 2025-12-31: -896333 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYRA HEALTH CORP. · 2025-12-31 SYRA HEALTH CORP. (edgar:1922335) Net Income: -896333 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -896333 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#748051 Filing: 000149315226009909 The citation records this snapshot. The page link may show a newer release later.	−USD 447,746 Exact value Exact value: -447746 USD 2025-01-01 – 2025-12-31: -447746 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYRA HEALTH CORP. · 2025-12-31 SYRA HEALTH CORP. (edgar:1922335) Operating Cash Flow: -447746 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -447746 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#761598 Filing: 000149315226009909 The citation records this snapshot. The page link may show a newer release later.	USD 107 Exact value Exact value: 107 USD 2025-01-01 – 2025-12-31: 107 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYRA HEALTH CORP. · 2025-12-31 SYRA HEALTH CORP. (edgar:1922335) Capital Expenditure: 107 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 107 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#763704 Filing: 000149315226009909 The citation records this snapshot. The page link may show a newer release later.	−USD 447,853 Calculation and evidence -447746 − 107 USD Exact free cash flow: -447853 USD 2025-01-01 – 2025-12-31: -447746 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 107 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYRA HEALTH CORP. · 2025-12-31 SYRA HEALTH CORP. (edgar:1922335) Free cash flow: -447853 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1922335?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -447746 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#761598 Filing: 000149315226009909 Input fundies:CapitalExpenditure: 107 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1922335/000149315226009909/form10-k.htm#763704 Filing: 000149315226009909 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

20 filings · 994 latest values · 994 originally reported values

Dataset published 2026-11-06. Source filing dates and reporting periods are shown separately.

Identifiers: 0001922335, 1922335, SYRA, edgar:1922335

Also known as SYRA HEALTH CORP., Syra Health Corp

SYRA HEALTH CORP.

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation